Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

ABVX

$88.714.48%3.80

Vorbörslich: 90.40+1.69 +1.91%

Abivax Adr (ABVX)

Date: O: H: L: C: Vol:

Abivax Adr Aktie (ABVX) Neueste Nachrichten

Abivax SA American Depositary Shares (ABVX) Stock Price, Chart & Analysis - www.debelegger.nl

Abivax to present at multiple fall investor con... - Pluang

Abivax SA (ABVX) Holds Near $87 as Shares Edge Higher Within a Balanced Trading Range - Rounding Top - https://www.dars.gov.et/

Abivax SA (ABVX) Holds Near $87 as Shares Edge Higher Within a Balanced Trading Range - Fibonacci Fan - https://www.dars.gov.et/

Abivax (ABVX) Stock Rises 5.00% to $92.38, Pressing Toward $97 Resistance - Revenue Weighted - siam.in

ABVX Q2 2026 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Keeps Spending on Pipeline - https://www.dars.gov.et/

ABVX Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Continues - Healthcare Earnings Report - https://www.dars.gov.et/

ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the Gap - Downward Estimate Revision - careplusvn.com

ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the Gap - Annual Earnings Summary - https://www.dars.gov.et/

ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the Gap - Forward Guidance Trends - dars.gov.et

ABVX Q4 2025 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Drives the Gap - Earnings Analysis - https://www.dars.gov.et/

Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline Progress - Low Growth Earnings - dars.gov.et

Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline Progress - EBITDA Estimate Trend - dars.gov.et

Abivax Q4 2025 Earnings: Wider-Than-Expected Loss Masks Investor Focus on Pipeline Progress - Revenue Breakdown Analysis - dars.gov.et

Abivax (ABVX) Edges Up 0.92% to $120.04, Hovering at Range Midpoint - Chart Pattern Alerts - dars.gov.et

Abivax (ABVX) Edges Up 0.92% to $120.04, Hovering at Range Midpoint - Hull Moving Average - dars.gov.et

Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's Why - Yahoo Finance

Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum Builds - Breadth Thrust - siam.in

Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum Builds - Weekly Profile - careplusvn.com

Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum Builds - Late Stage Breakouts - dars.gov.et

Abivax (ABVX) Jumps 3.62% to $118.95 as Biotech Momentum Builds - Dividend ETF - dars.gov.et

Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - GlobeNewswire Inc.

Readystate Asset Management LP Raises Stake in Abivax SA Sponsored ADR $ABVX - MarketBeat

Velan Capital Investment Management LP Sells 11,370 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat

Abivax SA Sponsored ADR $ABVX Stock Holdings Increased by Seven Fleet Capital Management LP - MarketBeat

Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et

Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period - dars.gov.et

Abivax (ABVX) Quarterly Scorecard: Profit Per Share Falls Below Its Benchmark in the Reported Period; Shares Finish 1.04% Up at the Close - Analyst Earnings Estimate - dars.gov.et

Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest Trading - EPS Surprise History - careplusvn.com

Abivax (ABVX) EPS and Revenue: EPS Misses Its Estimate in the Current Update; After Earnings: The Stock Loses 2.75% in Latest Trading - Earnings Sentiment Score - dars.gov.et

Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest Session - Earnings Quality Score - dars.gov.et

Abivax SA Sponsored ADR $ABVX Shares Sold by Royal Bank of Canada - MarketBeat

Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction: Shares Move Higher 1.36% in the Latest Session - Product Revenue Analysis - careplusvn.com

Abivax (ABVX) EPS and Revenue: The Available Earnings Metric Delivers a Miss on the Day; Latest Reaction - dars.gov.et

Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available Record - IPO Entry Watch - careplusvn.com

Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available Record - Last Point Support - dars.gov.et

Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available Record - Money Flow Index - dars.gov.et

Abivax (ABVX) Session-Level Review: Closes 1.51% Lower at $118.91 in the Current Update; Range Context: Traders Can Monitor the $112.96-$124.86 Range in the Available Record - Positive Gamma - dars.gov.et

Abivax (ABVX): TCG Crossover and Chen Yu report 7.0% ADS stake - Stock Titan

Abivax S.A. (ABVX) investors report 6.0% beneficial stake via Invus entities - Stock Titan

ABIVAX (NASDAQ:ABVX) Flashes Strong Technical Rating and Breakout Setup - ChartMill

Bank of America Corp DE Purchases 213,440 Shares of Abivax SA Sponsored ADR $ABVX - MarketBeat

Militia Capital Management LLC Makes New Investment in Abivax SA Sponsored ADR $ABVX - MarketBeat

Perceptive Advisors LLC Cuts Position in Abivax SA Sponsored ADR $ABVX - MarketBeat

Seven Fleet Capital Management LP Has $4.79 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat

Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Average Recommendation of "Moderate Buy" by Analysts - marketbeat.com

Avidity Partners Management LP Takes $1.11 Million Position in Abivax SA Sponsored ADR $ABVX - MarketBeat

Abivax SA Sponsored ADR $ABVX Shares Sold by Vivo Capital LLC - MarketBeat

ABVX Q4 2025 Earnings: Wider-than-Expected Net Loss, Shares Still Climb 4.62% - Earnings Quality Score - www.dars.gov.et

Stempoint Capital LP Has $34.94 Million Stock Position in Abivax SA Sponsored ADR $ABVX - MarketBeat

Ähnlich wie ABVX

PRAX$280.512.38%

AXSM$139.612.65%

ARWR$59.530.07%

CYTK$62.310.45%

IONS$40.421.99%